These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36443820)

  • 1. Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes.
    Wu Z; Yu S; Zhang H; Guo Z; Zheng Y; Xu Z; Li Z; Liu X; Li X; Chen S; Zhang J; Tao L; Guo X
    Cardiovasc Diabetol; 2022 Nov; 21(1):262. PubMed ID: 36443820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes.
    Nuamchit T; Siriwittayawan D; Thitiwuthikiat P
    Vasc Health Risk Manag; 2020; 16():343-352. PubMed ID: 32943869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.
    Kim KJ; Choi J; Bae JH; Kim KJ; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG; Kim NH
    Diabetes Metab J; 2021 May; 45(3):368-378. PubMed ID: 33081424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, glycemic control and arterial stiffness: a real-world cohort study in the context of predictive, preventive, and personalized medicine.
    Cui C; Zhang T; Qi Y; Chu J; Xu H; Sun C; Zhang Z; Wang X; Yue S; Kang X; Fang L
    EPMA J; 2023 Dec; 14(4):663-672. PubMed ID: 38094580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
    Sharif S; Visseren FLJ; Spiering W; de Jong PA; Bots ML; Westerink J;
    Diabet Med; 2019 Sep; 36(9):1125-1132. PubMed ID: 30920676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes.
    Cardoso CR; Salles GF
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors.
    Shah AS; El Ghormli L; Gidding SS; Bacha F; Nadeau KJ; Levitt Katz LE; Tryggestad JB; Leibel N; Hale DE; Urbina EM
    J Diabetes Complications; 2018 Aug; 32(8):740-745. PubMed ID: 29936086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes.
    Helleputte S; Calders P; Rodenbach A; Marlier J; Verroken C; De Backer T; Lapauw B
    Cardiovasc Diabetol; 2022 Dec; 21(1):277. PubMed ID: 36494687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness is elevated in normotensive type 2 diabetic patients with peripheral neuropathy.
    Chen Q; Chiheb S; Fysekidis M; Jaber Y; Brahimi M; Nguyen MT; Millasseau S; Cosson E; Valensi P
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1041-9. PubMed ID: 26474725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus.
    Li PI; Wang JN; Guo HR
    Diabetes Res Clin Pract; 2018 May; 139():72-80. PubMed ID: 29481816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Moran CB; Marinho FS; Ferreira MT; Salles GF
    Diabetologia; 2015 Sep; 58(9):2161-8. PubMed ID: 26044207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
    Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
    J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.
    van Wijngaarden RPT; Overbeek JA; Heintjes EM; Schubert A; Diels J; Straatman H; Steyerberg EW; Herings RMC
    Diabetes Ther; 2017 Oct; 8(5):1097-1109. PubMed ID: 28921256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
    Sabuncu T; Sonmez A; Eren MA; Sahin I; Çorapçioğlu D; Üçler R; Akin Ş; Haymana C; Demirci İ; Atmaca A; Ersöz HÖ; Satman I; Bayram F;
    Prim Care Diabetes; 2021 Apr; 15(2):332-339. PubMed ID: 33277201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    Fisher DP; Johnson E; Haneuse S; Arterburn D; Coleman KJ; O'Connor PJ; O'Brien R; Bogart A; Theis MK; Anau J; Schroeder EB; Sidney S
    JAMA; 2018 Oct; 320(15):1570-1582. PubMed ID: 30326126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
    Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD
    Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness.
    Smulyan H; Lieber A; Safar ME
    Am J Hypertens; 2016 Jan; 29(1):5-13. PubMed ID: 26156872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.